{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:21:33Z","timestamp":1790043693571,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bcmd.2010.10.011","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T06:00:49Z","timestamp":1291096849000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults"],"prefix":"10.1016","volume":"46","author":[{"given":"Pramod K.","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alexander","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Gwosdow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hangartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.10.011_bb0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0010","series-title":"The Online Metabolic and Molecular Basis of Inherited Metabolic Disease","author":"Grabowski","year":"2006"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0015","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0020","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","article-title":"Bone density in type 1 Gaucher disease","volume":"11","author":"Pastores","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0025","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1517\/14656566.9.11.1987","article-title":"Imiglucerase and its use for the treatment of Gaucher's disease","volume":"9","author":"Weinreb","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1399-0004.2007.00811.x","article-title":"Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease","volume":"71","author":"Weinreb","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0045","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.1992.03490170075028","article-title":"Bone gain in young adult women","volume":"268","author":"Recker","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI117034","article-title":"Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model","volume":"93","author":"Matkovic","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-198106060-00002","article-title":"Understanding the dose\u2013effect relationship: clinical application of pharmacokinetic\u2013pharmacodynamic models","volume":"6","author":"Holford","year":"1981","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0065","first-page":"4702","article-title":"Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study","volume":"84","author":"Bachrach","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbmr.5650100507","article-title":"Peak bone mass in young women","volume":"10","author":"Teegarden","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11914-009-0024-1","article-title":"Early life factors in the pathogenesis of osteoporosis","volume":"7","author":"Winsloe","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0080","author":"Kahn","year":"2009"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0085","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1359\/jbmr.2000.15.10.2011","article-title":"More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures","volume":"15","author":"Goulding","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0090","doi-asserted-by":"crossref","unstructured":"P. K. Mistry, J. Liu, M. Yang, et al., GBA1 deficient mice recapitulates Gaucher disease displaying system-wide cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci, USA (2010) Oct 20 [Epub ahead of print].","DOI":"10.1016\/j.ymgme.2010.11.101"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0095","first-page":"1094","article-title":"Phenotype\/genotype correlations in Gaucher disease type I: clinical and therapeutic implications","volume":"52","author":"Sibille","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0100","article-title":"Fitting of bone mineral density with consideration of anthropometric parameters","author":"Short","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0120","series-title":"Markers of bone metabolism: should current concept of bone disease in Gaucher patients be remodeled?, 9th European Working Group on Gaucher Disease, Cologne, Germany","author":"Van Dussen","year":"2010"},{"key":"10.1016\/j.bcmd.2010.10.011_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7863\/jum.1997.16.3.209","article-title":"Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements","volume":"16","author":"Elstein","year":"1997","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.bcmd.2010.10.011_bb0130","first-page":"1","article-title":"CDC growth charts: United States","author":"Kuczmarski","year":"2000","journal-title":"Adv. Data"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:28:15Z","timestamp":1761049695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1079979610002524"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.011","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}